The deletions are found to be more common in METTL16, ALKBH5, RBM15B, METTL14, ZC3H13, YTHDF2, WTAP, ZCCHC4, RBFOX2, YTHDC1, YTHDC2, RBM15, METTL3, HNRNPC, FTO, TRMT112, and RBMX, whereas amplifications are more common in FMR1, METTL5, PRRC2A, IGF2BP1, LRPPRC, IGF2BP2, FXR1, RBM33, CBLL1, YTHDF3, HNRNPA2B1, IGF2BP3, VIRMA, and YTHDF1 in most tumor types. This evidence concerns the gene IGF2BP3 and neoplasm.